Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the EORTC - Protocol 30892

Franciscus Keuppens, Eortc Gu Group

Research output: Contribution to journalArticle

62 Citations (Scopus)
Original languageEnglish
Pages (from-to)457-464
Number of pages8
JournalEuropean Urology
Volume45
Publication statusPublished - 2004

Keywords

  • METASTATIC PROSTATE CANCER
  • FLUTAMIDE
  • CYPROTERONE ACETATE

Cite this